Literature DB >> 6298396

Vasoactive intestinal peptide producing neuroblastoma.

D R Cooney, M L Voorhess, J E Fisher, M Brecher, M P Karp, T C Jewett.   

Abstract

The Verner-Morrison syndrome has been described in 19 previous patients with ganglioneuroma and ganglioneuroblastoma but never neuroblastoma. Its occurrence following treatment of a neuroblastoma with chemotherapy with maturation of the tumor has only been reported on one previous occasion. Our case suggests that vasoactive intestinal polypeptide may be used not only as a diagnostic indicator for the presence of a neural crest tumor but also as a marker to monitor maturation of the tumor and indicate an improving prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298396     DOI: 10.1016/s0022-3468(82)80450-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide.

Authors:  L N Contreras; D Budd; T S Yen; C Thomas; J B Tyrrell
Journal:  West J Med       Date:  1991-03

Review 2.  VIP secreting tumours in infancy. A review of radiological appearances.

Authors:  R P Davies; J P Slavotinek; S F Dorney
Journal:  Pediatr Radiol       Date:  1990

3.  Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.

Authors:  S E Bates; L A Mickley; Y N Chen; N Richert; J Rudick; J L Biedler; A T Fojo
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 5.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.